Evidence map›Paper›PMID 30660496›Full record

ReviewBiochemical pharmacology2019

Targeting intrinsic cell death pathways to control fungal pathogens.

Madhura Kulkarni, Zachary D Stolp, J Marie Hardwick

Abstract readReview
In one paragraph

Review in Biochemical pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Specifically Targeting Metacaspases ofJournal of fungi (Basel, Switzerland) · 2024
    Review
  10. Article
  11. Review
  12. Review
  13. Heliyon · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Programmed Cell Death inGenetics · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Madhura KulkarniDepartment of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, USA.
Zachary D StolpDepartment of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, USA.
J Marie HardwickDepartment of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, USA; Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, USA. Electronic address: hardwick@jhu.edu.

Funding

Training: Molecular & Cellular Bases of Infectious DiseasesT32AI007417 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Arturo Casadevall · 1994 to 2026
$11.9M
Mechanisms of NeurodegenerationR01NS083373 · NINDS · JOHNS HOPKINS UNIVERSITY · PI HARDWICK, J. MARIE · 2013 to 2017
$1.8M
Conserved Cell Death Pathways in Mammals and YeastR01GM077875 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI HARDWICK, J. MARIE · 2006 to 2010
$1.4M
NIAID NIH HHS T32 AI007417NIGMS NIH HHS R01 GM077875NINDS NIH HHS R01 NS083373
6 · The paper itself

Abstract

Fungal pathogens pose an increasing threat to public health. Limited clinical drug regimens and emerging drug-resistant isolates challenge infection control. The global burden of human fungal pathogens is estimated at 1 billion infections and 1.5 million deaths annually. In addition, plant fungal pathogens increasingly threaten global food resources. Novel strategies are needed to combat emerging fungal diseases and pan-resistant fungi. An untapped mechanistically novel approach is to pharmacologically activate the intrinsic cell death pathways encoded by pathogenic fungi. This strategy is analogous to new anti-cancer therapeutics now entering the clinic. Here we summarize the best understood examples of cell death mechanisms encoded by pathogenic fungi, contrast these to mammalian cell death pathways, and highlight the gaps in knowledge towards identifying potential death effectors as druggable targets.

Indexed as

AnimalsAntifungal AgentsCell DeathDrug Delivery SystemsFungiHumansMycosesSignal TransductionAntifungal AgentsApoptosisCell deathFungiNecrosisPathogenYeast

Identifiers

PMID30660496
PMCPMC6430978

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.